These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12871683)

  • 1. Nicorandil: a drug for many purposes: too good to be true?
    Eeckhout E
    Eur Heart J; 2003 Jul; 24(14):1282-4. PubMed ID: 12871683
    [No Abstract]   [Full Text] [Related]  

  • 2. Nicorandil. An updated review of its use in ischaemic heart disease with emphasis on its cardioprotective effects.
    Markham A; Plosker GL; Goa KL
    Drugs; 2000 Oct; 60(4):955-74. PubMed ID: 11085202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of nicorandil in the treatment of myocardial ischaemia.
    Falase B; Easaw J; Youhana A
    Expert Opin Pharmacother; 2001 May; 2(5):845-56. PubMed ID: 11336627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicorandil for angina--an update.
    Drug Ther Bull; 2003 Nov; 41(11):86-8. PubMed ID: 14658416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical use of potassium channel activators in angina pectoris: efficacy and tolerance].
    Specchia G; Marsico F; Micheletti T; Bona M
    Cardiologia; 1995 Dec; 40(12 Suppl 1):91-5. PubMed ID: 8998788
    [No Abstract]   [Full Text] [Related]  

  • 6. Prescribing for angina.
    Shetty K
    Practitioner; 1994 Jul; 238(1540):540-2. PubMed ID: 7937508
    [No Abstract]   [Full Text] [Related]  

  • 7. Nicorandil: the drug that keeps on giving.
    Barbato JC
    Hypertension; 2005 Oct; 46(4):647-8. PubMed ID: 16172416
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapeutic application of myocardial cytoprotection].
    Ribeiro C
    Rev Port Cardiol; 1994 Sep; 13(9):669-70. PubMed ID: 7818940
    [No Abstract]   [Full Text] [Related]  

  • 9. Nicorandil: a review of its use in the management of stable angina pectoris, including high-risk patients.
    Simpson D; Wellington K
    Drugs; 2004; 64(17):1941-55. PubMed ID: 15329045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potassium channel openers in myocardial ischaemia: therapeutic potential of nicorandil.
    Gomma AH; Purcell HJ; Fox KM
    Drugs; 2001; 61(12):1705-10. PubMed ID: 11693460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicorandil was an Effective Treatment Option for a Patient with Bland-White-Garland Syndrome.
    Morishita S; Maeba H; Takehana K; Shiojima I
    Intern Med; 2017 Sep; 56(17):2295-2299. PubMed ID: 28794372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Nicorandil and ulceration: a physiopathological hypothesis].
    Schmutz JL; Trechot P
    Ann Dermatol Venereol; 2012 Mar; 139(3):249-50. PubMed ID: 22401699
    [No Abstract]   [Full Text] [Related]  

  • 13. Chronic stable angina pectoris.
    Jawad E; Arora R
    Dis Mon; 2008 Sep; 54(9):671-89. PubMed ID: 18725007
    [No Abstract]   [Full Text] [Related]  

  • 14. [Nicorandil in the treatment of patients with ischemic heart disease].
    Minushkina LO; Sidorenko BA
    Kardiologiia; 2013; 53(5):69-73. PubMed ID: 23952998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perianal ulceration and other cutaneous ulcerations complicating nicorandil therapy.
    Williams C; Tamuno P; Smith AJ; Walker SL; Lyon CC
    J Am Acad Dermatol; 2007 May; 56(5 Suppl):S116-7. PubMed ID: 17434035
    [No Abstract]   [Full Text] [Related]  

  • 16. Novel drugs for treating angina.
    Jones DA; Timmis A; Wragg A
    BMJ; 2013 Sep; 347():f4726. PubMed ID: 24018101
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of the efficacy of nicorandil in patients with ischemic heart disease by exercise Tl-201 myocardial SPECT.
    Yamazaki J; Iida M; Igarashi M; Hosoi H; Ishiguro S; Hou M; Morishita T; Nakano H; Yabe Y; Koyama N
    Int J Clin Pharmacol Ther; 1994 Apr; 32(4):183-91. PubMed ID: 8032578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of an angiotensin-converting enzyme inhibitor and a K+(ATP) channel opener on warm up angina.
    Edwards RJ; Redwood SR; Lambiase PD; Marber MS
    Eur Heart J; 2005 Mar; 26(6):598-606. PubMed ID: 15618027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potassium channel activators in the management of ischaemic heart disease: a focus on nicorandil.
    Purcell H; Fox K
    Br J Clin Pract; 1993; 47(3):150-4. PubMed ID: 8347442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial.
    IONA Study Group
    Lancet; 2002 Apr; 359(9314):1269-75. PubMed ID: 11965271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.